Clinical Trials in Maryland

Showing 5661-5680 of 17,687 trials

A Chatbot Intervention for Reducing HPV Vaccine Hesitancy

NCT05959564

The goal of this project is to test the efficacy of a chatbot intervention for reducing HPV vaccine hesitancy among African American parents. An online experiment will be conducted to test the effectiveness of the chatbot intervention with African American parents. Results of this project will inform future communication interventions for reducing vaccine hesitancy among African American parents.

Cervical CancerAnal CancerPenile Cancer

University of Maryland, College Park456 participantsStarted Jul 2023

College Park, Maryland, United States

COMPLETEDPhase 319 miles

Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure

NCT04286438

This is a multi-center, open-label, prospective single-arm study of reversal of the antiplatelet effects of ticagrelor with bentracimab (PB2452) in patients who present with uncontrolled major or life-threatening bleeding or who require urgent surgery or invasive procedure. At least 200 patients will be enrolled from approximately 200 centers in North America, Europe, and Asia-Pacific regions, including mainland China. Patients with reported use of ticagrelor within the prior 3 days who require urgent ticagrelor reversal will be eligible for enrollment. These populations will be enrolled based on separate inclusion criteria.

HemorrhageUrgent SurgeryInvasive Procedure

SFJ Pharmaceuticals, Inc.226 participantsStarted Jul 2020

Jacksonville, Florida, United States • Lexington, Kentucky, United States • Baltimore, Maryland, United States +65 more locations

A Chatbot Intervention for Reducing HPV Vaccine Hesitancy

Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure

Find Trials by Condition in Maryland

A Study to Assess Bioequivalence of Fezolinetant Formulations in Healthy Female Participants

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Assessment of Macrophage Activation syndromE in STill's Disease

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

Hypotension Prediction Index Study (HPI Study)

A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

Vitamin D to Improve Outcomes by Leveraging Early Treatment: Long-term Brain Outcomes in Vitamin D Deficient Patients

Milademetan in Advanced/Metastatic Solid Tumors

PK and Dose Escalation and Expansion Study of DST-2970

Stockholm3 Validation Study in a Multi-Ethnic Cohort

SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission

Vogelxo(R) ABPM Study in Hypogandal Men

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer

MK-2060 and Clopidogrel Co-administration Safety and Tolerability Study in Participants With End-Stage Renal Disease (ESRD) (MK-2060-008)